-BioMap’s AI drug discovery platform integrates foundational large language models and super-scale computing with cutting-edge biotechnology to discover novel targets and design biologics through a ...
Researchers at the University of California, Santa Cruz, have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical ...
Scientists have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources. The research was ...
New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct protein design categories BioMap’s "xTrimo" 100B-parameter cross-modal ...
- 24 June 2024 - Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park company, on its strategic partnership with the Hong Kong Investment Corporation Limited (HKIC) to jointly ...
BioMAP® assays are human primary cell-based assays that read out a unique signature of biological activity for every active compound including both drug candidates and a wide range of chemicals. Using ...
Researchers show that bioactivity fingerprinting can help with profiling antibiotic lead compounds. Screening of annotated compound collections across a panel of assays can provide bioactivity ...
SAN FRANCISCO--(BUSINESS WIRE)--Assessments of the biological activity of various nanomaterials and chemicals in the context of primary human cell biology were presented today at the annual meeting of ...
Robotic equipment at the UCSC Chemical Screening Center was used to screen natural product extracts for novel antibiotics. Researchers at the University of California, Santa Cruz, have developed a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback